DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,572 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,576,943 | +16.2% | 50,338 | +16.2% | 0.69% | +13.0% |
Q1 2024 | $10,820,054 | +10.1% | 43,329 | +2.0% | 0.61% | -1.6% |
Q4 2023 | $9,831,148 | -4.1% | 42,497 | +2.9% | 0.62% | -15.2% |
Q3 2023 | $10,247,086 | +3.4% | 41,302 | +0.1% | 0.73% | +5.6% |
Q2 2023 | $9,906,008 | -5.5% | 41,275 | -0.7% | 0.69% | -11.4% |
Q1 2023 | $10,480,023 | -6.0% | 41,581 | -1.0% | 0.78% | -9.6% |
Q4 2022 | $11,143,288 | +0.1% | 41,984 | -2.6% | 0.86% | -6.7% |
Q3 2022 | $11,135,000 | +4.1% | 43,109 | +2.1% | 0.93% | +9.3% |
Q2 2022 | $10,699,000 | -12.9% | 42,202 | +0.7% | 0.85% | +2.5% |
Q1 2022 | $12,289,000 | -6.9% | 41,895 | +4.4% | 0.83% | -3.7% |
Q4 2021 | $13,197,000 | +1.8% | 40,111 | -5.8% | 0.86% | -0.9% |
Q3 2021 | $12,960,000 | +14.0% | 42,570 | +0.5% | 0.87% | +5.4% |
Q2 2021 | $11,367,000 | +20.6% | 42,357 | +1.2% | 0.82% | +10.9% |
Q1 2021 | $9,422,000 | +0.2% | 41,863 | -1.1% | 0.74% | -2.6% |
Q4 2020 | $9,401,000 | +10.8% | 42,322 | +7.4% | 0.76% | -10.7% |
Q3 2020 | $8,482,000 | +26.8% | 39,389 | +4.1% | 0.85% | +17.5% |
Q2 2020 | $6,691,000 | +22.3% | 37,838 | -4.3% | 0.72% | +1.5% |
Q1 2020 | $5,470,000 | -5.9% | 39,520 | +4.3% | 0.71% | +18.2% |
Q4 2019 | $5,813,000 | +9.0% | 37,873 | +2.6% | 0.60% | +0.5% |
Q3 2019 | $5,331,000 | +3.1% | 36,913 | +2.0% | 0.60% | +1.2% |
Q2 2019 | $5,173,000 | +4.2% | 36,194 | -3.8% | 0.59% | +1.7% |
Q1 2019 | $4,966,000 | +40.4% | 37,613 | +9.7% | 0.58% | +20.4% |
Q4 2018 | $3,536,000 | +14.5% | 34,293 | +20.6% | 0.48% | +26.3% |
Q3 2018 | $3,089,000 | +24.2% | 28,429 | +12.8% | 0.38% | +13.6% |
Q2 2018 | $2,487,000 | +0.2% | 25,203 | -0.6% | 0.34% | +1.8% |
Q1 2018 | $2,481,000 | +8.1% | 25,344 | +2.5% | 0.33% | +1.2% |
Q4 2017 | $2,295,000 | +9.8% | 24,729 | +1.4% | 0.33% | +1.9% |
Q3 2017 | $2,091,000 | +2.8% | 24,379 | +1.2% | 0.32% | -4.5% |
Q2 2017 | $2,034,000 | +2.1% | 24,098 | +3.5% | 0.34% | -0.3% |
Q1 2017 | $1,992,000 | +12.3% | 23,293 | +2.2% | 0.34% | +9.4% |
Q4 2016 | $1,774,000 | +1.4% | 22,793 | +2.1% | 0.31% | -2.8% |
Q3 2016 | $1,750,000 | -5.7% | 22,323 | +21.5% | 0.32% | -9.1% |
Q2 2016 | $1,855,000 | +7.2% | 18,368 | +0.7% | 0.35% | +0.6% |
Q1 2016 | $1,730,000 | +2.1% | 18,235 | 0.0% | 0.35% | -2.8% |
Q4 2015 | $1,694,000 | +8.7% | 18,235 | -0.3% | 0.36% | +3.8% |
Q3 2015 | $1,558,000 | -2.7% | 18,285 | -2.2% | 0.34% | +3.6% |
Q2 2015 | $1,601,000 | +1.3% | 18,705 | +0.5% | 0.33% | +1.2% |
Q1 2015 | $1,580,000 | -4.8% | 18,605 | -3.9% | 0.33% | -6.3% |
Q4 2014 | $1,659,000 | +12.8% | 19,355 | 0.0% | 0.35% | +10.4% |
Q3 2014 | $1,471,000 | -8.7% | 19,355 | -5.4% | 0.32% | -7.6% |
Q2 2014 | $1,611,000 | +4.5% | 20,465 | -0.4% | 0.34% | +1.2% |
Q1 2014 | $1,542,000 | -3.2% | 20,555 | -0.4% | 0.34% | -10.8% |
Q4 2013 | $1,593,000 | +10.5% | 20,635 | -0.7% | 0.38% | +0.3% |
Q3 2013 | $1,441,000 | +3.1% | 20,785 | -5.9% | 0.38% | -2.3% |
Q2 2013 | $1,398,000 | – | 22,085 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |